Insider Trading & Ownership of Keith Crandell

Location: Chicago, IL
Summary: The estimated net worth of Keith Crandell is at least $108,781,985 dollars as of 09 Feb 2026. Keith Crandell is the 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $68.45M. Keith Crandell is the Director, 10%+ Owner of 908 Devices Inc. and owns shares of 908 Devices Inc. (MASS) stock worth about $26.74M. Keith Crandell is the Director, 10%+ Owner of DA32 Life Science Tech Acquisition Corp. and owns shares of DA32 Life Science Tech Acquisition Corp. stock worth about $6.5M. Keith Crandell is the Director of Twist Bioscience Corp and owns shares of Twist Bioscience Corp (TWST) stock worth about $3.56M. Keith Crandell is the Director of Quanterix Corp and owns shares of Quanterix Corp (QTRX) stock worth about $3.53M.
Signature: /s/ Kendra Fox, as Attorney-in-Fact for Keith Crandell
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Keith Crandell and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

Keith Crandell has 7 issuer positions tracked on this page.
Estimated disclosed ownership value: $108,781,985.
Recent insider filing activity is available below.

What Changed

Largest disclosed position: Sana Biotechnology, Inc. ($68,453,121).
Past-year value change for that position: .

Why This Matters

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.